Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced that it is, together with C.R. Bard, a 2012 winner of Microsoft Corporation’s prestigious Life Sciences Innovation Award. The awards, announced at the Drug ...
read more
BioClinica, Inc., a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab ...
read more
BioClinica®, Inc., a global provider of clinical trial management services, has recently announced several major initiatives to better serve its growing sponsor client base in China and other Asia Pacific countries, following its March 2013 merger ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced today the introduction of StudyView™, a clinical trials portal and reporting hub that dramatically increases clinical trials operational visibility. StudyView ...
read more
Bioclinica® has assembled a team of experts dedicated to NAFLD and NASH to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.
read more
BioClinica®, Inc., has announced that David Peters, an accomplished senior finance and accounting executive, has been named Executive Vice President and Chief Financial Officer (CFO) and will be joining BioClinica on June 8, 2015.
read more
Friday, September 11, 2020
Direct Biologics will leverage Bioclinica's Interactive Response Technology (IRT) for their EXIT COVID-19 study.
read more
Thursday, October 04, 2012
BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in October, November, and December. ...
read more
Wednesday, April 18, 2012
BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and speak at several upcoming industry conferences in April, May, and June. BioClinica ...
read more
BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in July, August, and ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, today announced that members of its team will attend, participate in and lead discussions at several upcoming industry conferences in January, February, and March. ...
read more
Wednesday, September 25, 2019
Biocon Biologics has acquired R&D capital assets for a 60,000 sq. ft ‘bench to pilot scale’ Biologics research facility at TICEL Bio Park in Chennai from Pfizer Healthcare India.
read more
BioConnection, an independent CDMO based in Oss, The Netherlands announced the completion of a new capital raising led by the European investment company Gimv, and supported by existing shareholders Pharming Group N.V., Mibiton and BioConnection’s ...
read more
Monday, November 29, 2021
BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that Nykode Therapeutics AS...
read more